2,363
Views
62
CrossRef citations to date
0
Altmetric
Research Papers

KIFC1 is a novel potential therapeutic target for breast cancer

, , , , , , , & show all
Pages 1316-1322 | Received 08 Dec 2014, Accepted 03 Jul 2015, Published online: 08 Aug 2015

References

  • Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nature Rev Cancer 2007; 7:911-24; http://dx.doi.org/10.1038/nrc2249.
  • Ogden A, Rida PC, Aneja R. Let's huddle to prevent a muddle: Centrosome declustering as an attractive anticancer strategy. Cell Death Differ 2012; 19:1255-67; PMID:22653338; http://dx.doi.org/10.1038/cdd.2012.61.
  • Anderhub SJ, Kramer A, Maier B. Centrosome amplification in tumorigenesis. Cancer Lett 2012; 322:8-17; PMID:22342684; http://dx.doi.org/10.1016/j.canlet.2012.02.006.
  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998; 58:3974-85; PMID:9731511.
  • Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T, Tanaka M. Centrosome abnormalities in pancreatic ductal carcinoma. Clin Cancer Res 1999; 5:963-70; PMID:10353727.
  • Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61:2212-9; PMID:11280789.
  • Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, Nojima T, Levin LS, Fujikawa-Yamamoto K, Suzuki K, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin e overexpression. Cancer Res 2004; 64:4800-9; PMID:15256449; http://dx.doi.org/10.1158/0008-5472.CAN-03-3908.
  • Zyss D, Gergely F. Centrosome function in cancer: Guilty or innocent? Trends Cell Biol 2009; 19:334-46; PMID:19570677; http://dx.doi.org/10.1016/j.tcb.2009.04.001.
  • Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, Pellman D. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008; 22:2189-203; PMID:18662975; http://dx.doi.org/10.1101/gad.1700908.
  • Kleylein-Sohn J, Pollinger B, Ohmer M, Hofmann F, Nigg EA, Hemmings BA, Wartmann M. Acentrosomal spindle organization renders cancer cells dependent on the kinesin hset. J Cell Sci 2012; 125:5391-402; PMID:22946058; http://dx.doi.org/10.1242/jcs.107474.
  • Castiel A, Visochek L, Mittelman L, Dantzer F, Izraeli S, Cohen-Armon M. A phenanthrene derived parp inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells. BMC Cancer 2011; 11:412; PMID:21943092; http://dx.doi.org/10.1186/1471-2407-11-412.
  • Antolin AA, Jalencas X, Yelamos J, Mestres J. Identification of pim kinases as novel targets for pj34 with confounding effects in parp biology. ACS Chem Biol 2012; 7:1962-7; PMID:23025350; http://dx.doi.org/10.1021/cb300317y.
  • Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajduch M, Jacob-Hirsch J, Amariglio N, Krupsky M, Simansky DA, et al. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 2009; 15:1755-61; PMID:19190132; http://dx.doi.org/10.1158/1078-0432.CCR-08-2124.
  • De S, Cipriano R, Jackson MW, Stark GR. Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. Cancer Res 2009; 69:8035-42; PMID:19789344; http://dx.doi.org/10.1158/0008-5472.CAN-09-1224.
  • Wu J, Mikule K, Wang W, Su N, Petteruti P, Gharahdaghi F, Code E, Zhu X, Jacques K, Lai Z, et al. Discovery and mechanistic study of a small molecule inhibitor for motor protein kifc1. ACS Chem Biol 2013; 8:2201-8; PMID:23895133; http://dx.doi.org/10.1021/cb400186w.
  • Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. Parp inhibition: Parp1 and beyond. Nature Rev Cancer 2010; 10:293-301; http://dx.doi.org/10.1038/nrc2812.
  • Davar D, Beumer JH, Hamieh L, Tawbi H. Role of parp inhibitors in cancer biology and therapy. Curr Med Chem 2012; 19:3907-21; PMID:22788767; http://dx.doi.org/10.2174/092986712802002464.
  • Kanai M, Uchida M, Hanai S, Uematsu N, Uchida K, Miwa M. Poly(adp-ribose) polymerase localizes to the centrosomes and chromosomes. Biochem Biophys Res Commun 2000; 278:385-9; PMID:11097846; http://dx.doi.org/10.1006/bbrc.2000.3801.
  • Kanai M, Tong WM, Sugihara E, Wang ZQ, Fukasawa K, Miwa M. Involvement of poly(adp-ribose) polymerase 1 and poly(adp-ribosyl)ation in regulation of centrosome function. Mol Cell Biol 2003; 23:2451-62; PMID:12640128; http://dx.doi.org/10.1128/MCB.23.7.2451-2462.2003.
  • Kanai M, Tong WM, Wang ZQ, Miwa M. Haploinsufficiency of poly(adp-ribose) polymerase-1-mediated poly(adp-ribosyl)ation for centrosome duplication. Biochem Biophys Res Commun 2007; 359:426-30; PMID:17553458; http://dx.doi.org/10.1016/j.bbrc.2007.05.108.
  • Augustin A, Spenlehauer C, Dumond H, Menissier-De Murcia J, Piel M, Schmit AC, Apiou F, Vonesch JL, Kock M, Bornens M, et al. Parp-3 localizes preferentially to the daughter centriole and interferes with the g1/s cell cycle progression. J Cell Sci 2003; 116:1551-62; PMID:12640039; http://dx.doi.org/10.1242/jcs.00341.
  • Toller IM, Altmeyer M, Kohler E, Hottiger MO, Muller A. Inhibition of adp ribosylation prevents and cures helicobacter-induced gastric preneoplasia. Cancer Res 2010; 70:5912-22; PMID:20634404; http://dx.doi.org/10.1158/0008-5472.CAN-10-0528.
  • Madison DL, Stauffer D, Lundblad JR. The parp inhibitor pj34 causes a parp1-independent, p21 dependent mitotic arrest. DNA Repair 2011; 10:1003-13; PMID:21840268; http://dx.doi.org/10.1016/j.dnarep.2011.07.006.
  • Watts CA, Richards FM, Bender A, Bond PJ, Korb O, Kern O, Riddick M, Owen P, Myers RM, Raff J, et al. Design, synthesis, and biological evaluation of an allosteric inhibitor of hset that targets cancer cells with supernumerary centrosomes. Chem Biol 2013; 20:1399-410; PMID:24210220; http://dx.doi.org/10.1016/j.chembiol.2013.09.012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.